Related Experiment Videos
Inhibition of signal transduction in EGF-dependent epithelial cell lines
1Department of Dermatology, Krankenhaus Dresden-Friedrichstadt, Friedrichstrasse 41, 01067 Dresden, Germany. wollina-uw@khdf.de
Abstract:
The epidermal growth factor (EGF) receptor plays a pivotal role in growth regulation of epidermal keratinocytes. Its expression and function can be markedly altered during malignant transformation in squamous cell carcinoma. The present study investigated the potential of growth inhibition by signal-transduction inhibitors in EGF-dependent epithelial cell lines in vitro. Benign HaCaT keratinocytes and malignant A431 cells were grown in vitro and exposed to various concentrations of a panel of eleven kinase and phosphodiesterase inhibitors. Cell growth was measured after 24 h and 48 h using fluorescence labeling with Hoechst 33342 and propidium iodide. Significant growth inhibition was achieved with all inhibitors when applied to HaCaT cells. The strongest growth inhibition was achieved with inhibitors H-7, A3 and diacylglycerol kinase inhibitors I and II. A431 cells were inhibited significantly by H-7, A3 and H-9. Selected signal-transduction inhibitors such as A3, H-7 and H-9 acting on intracellular kinases are capable of suppressing growth of EGF-dependent benign and malignant epithelial cell lines in vitro. They might be of future potential in the treatment of epithelial cancer but further studies are necessary.
Insights
Signal-transduction inhibitors show promise for treating epithelial cancers. Specific inhibitors like H-7, A3, and H-9 effectively suppressed the growth of both benign and malignant epithelial cells in laboratory studies.
Area of Science:
- Cell Biology
- Oncology
- Pharmacology
Background:
- The epidermal growth factor (EGF) receptor is crucial for epidermal keratinocyte growth regulation.
- EGF receptor expression and function are altered during squamous cell carcinoma development.
Purpose of the Study:
- To investigate the growth inhibitory potential of signal-transduction inhibitors on EGF-dependent epithelial cell lines in vitro.
- To evaluate the efficacy of kinase and phosphodiesterase inhibitors against benign and malignant epithelial cells.
Main Methods:
- Utilized benign HaCaT keratinocytes and malignant A431 cells in in vitro cultures.
- Exposed cells to eleven kinase and phosphodiesterase inhibitors at various concentrations.
- Measured cell growth after 24 and 48 hours using Hoechst 33342 and propidium iodide fluorescence labeling.
Main Results:
- All tested inhibitors significantly inhibited growth in HaCaT cells.
- H-7, A3, and diacylglycerol kinase inhibitors I and II demonstrated the strongest inhibition in HaCaT cells.
- H-7, A3, and H-9 significantly inhibited growth in A431 cells.
Conclusions:
- Selected signal-transduction inhibitors (A3, H-7, H-9) targeting intracellular kinases can suppress the growth of EGF-dependent benign and malignant epithelial cells.
- These inhibitors hold potential for future epithelial cancer treatment, warranting further investigation.